A case report of type 2 diabetes mellitus with biatrial thrombi and pulmonary embolism caused by atrial fibrillation: Successful treatment with anticoagulant therapy

被引：0

作者：

Inoue T. ^{[1
,2
]}

Kobayashi K. ^{[2
]}

Katsuragi T. ^{[1
]}

Ichino I. ^{[1
]}

Tanaka S. ^{[1
]}

Haji M. ^{[1
]}

Inoguchi T. ^{[2
,3
]}

Takayanagi R. ^{[2
]}

机构：

[1] Department of Internal Medicine, Kyushu Rosai Hospital, Labour Welfare Corporation, Kitakyushu, 800-0296, 1-3-1 Kuzuharatakamatsu, Kokuraminami-ku

[2] Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, 3-1-1 Maidashi, Higashi-ku

[3] Innovation Center for Medical Redox Navigation, Fukuoka, 812-8582, 3-1-1, Maidashi, Higashi-ku

来源：

Diabetology International | 2011年 / 2卷 / 4期

关键词：

Anticoagulation; Atrial fibrillation; Biatrial thrombi; Diabetes mellitus; Pulmonary embolism;

D O I：

10.1007/s13340-011-0047-6

中图分类号：

学科分类号：

摘要：

A 75-year-old woman with a history of type 2 diabetes mellitus was admitted to our hospital with symptoms of asthenia. Laboratory results demonstrated a severe inflammatory response, abnormal kidney function, and hyperglycemia. Electrocardiography revealed atrial fibrillation. The patient was treated with antibiotics and insulin injection upon admission, and laboratory data relating to inflammation, kidney, and blood glucose level gradually improved. On the 4th day of hospitalization, chest contrast-enhanced computed tomography showed the existence of masses in both atria and the right pulmonary artery. The differential diagnosis of the left atrial mass included a thrombus and a neoplasm, such as an atrial myxoma. Because surgical removal of the masses, presumed to be thrombi, was declined by the patient, anticoagulation therapy (heparin i. v. followed by warfarin) was initiated. After 12 months of anticoagulation therapy, the masses disappeared completely without systemic embolization. © 2011 The Japan Diabetes Society.

引用

页码：219 / 222

页数：3

共 20 条

[1]

Abe Y., Asakura T., Gotou J., Iwai M., Watanabe Y., Sando M., Ishikawa S., Nagata K., Saito T., Maehara K., Maruyama Y., Prediction of embolism in atrial fibrillation: classification of left atrial thrombi by transesophageal echocardiography, Jpn Circ J, 64, pp. 411-415, (2000)

[2]

Movahed M.R., Hashemzadeh M., Jamal M.M., Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease, Int J Cardiol, 105, pp. 315-318, (2005)

[3]

Carr M.E., Diabetes mellitus: a hypercoagulable state, J Diabetes Complic, 15, pp. 44-54, (2001)

[4]

Aneja A., Tang W.H., Bansilal S., Garcia M.J., Farkouh M.E., Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options, Am J Med, 121, pp. 748-757, (2008)

[5]

Wrisley D., Giambartolomei A., Lee I., Brownlee W., Left atrial ball thrombus: review of clinical and echocardiographic manifestations with suggestions for management, Am Heart J, 121, pp. 1784-1790, (1991)

[6]

Waller B.F., Grider L., Rohr T.M., McLaughlin T., Taliercio C.P., Fetters J., Intracardiac thrombi: frequency, location, etiology, and complications: a morphologic review, Clin Cardiol, 18, pp. 477-479, (1995)

[7]

Wysokinski W.E., Ammash N., Sobande F., Kalsi H., Hodge D., McBane R.D., Predicting left atrial thrombi in atrial fibrillation, Am Heart J, 159, pp. 665-671, (2010)

[8]

Reynen K., Cardiac myxomas, N Engl J Med, 333, pp. 1610-1617, (1995)

[9]

Maze Y., Kajimoto M., Tenpaku H., Satou T., Left atrial myxoma with severe inflammatory response, Jpn J Thorac Cardiovasc Surg, 52, pp. 221-223, (2004)

[10]

Dedeilias P., Roussakis A., Koletsis E.N., Zervakis D., Hountis P., Prokakis C., Balaka C., Bolos K., Left atrial giant thrombus infected by Escherichia Coli. Case report, J Cardiothorac Surg, 3, (2008)

← 1 2 →